When should the effectiveness of a botulinum toxin A for chronic migraine be assessed in the face of newest International Headache Society recommendations?

IF 4.6 2区医学 Q1 CLINICAL NEUROLOGY

Cephalalgia Pub Date : 2025-07-01 Epub Date: 2025-07-30 DOI:10.1177/03331024251363268

Magdalena Boczarska-Jedynak, Andrew M Blumenfeld

引用次数: 0

查看原文本刊更多论文

面对国际头痛协会的最新建议，何时应该评估a型肉毒杆菌毒素治疗慢性偏头痛的有效性？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cephalalgia 医学-临床神经学

CiteScore

10.10

自引率

6.10%

发文量

108

审稿时长

4-8 weeks

期刊介绍： Cephalalgia contains original peer reviewed papers on all aspects of headache. The journal provides an international forum for original research papers, review articles and short communications. Published monthly on behalf of the International Headache Society, Cephalalgia''s rapid review averages 5 ½ weeks from author submission to first decision.